Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.

about

Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.

Item

http://www.wikidata.org/entity/Q51603922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of neratinib and combi ...... in head and neck cancer cells.

@en

Effects of neratinib and combi ...... in head and neck cancer cells.

@nl

type

Item

label

Effects of neratinib and combi ...... in head and neck cancer cells.

@en

Effects of neratinib and combi ...... in head and neck cancer cells.

@nl

prefLabel

Effects of neratinib and combi ...... in head and neck cancer cells.

@en

Effects of neratinib and combi ...... in head and neck cancer cells.

@nl

P1476

Effects of neratinib and combi ...... in head and neck cancer cells

@en

P2093

C Lill

http://www.w3.org/2001/XMLSchema#string

D Thurnher

http://www.w3.org/2001/XMLSchema#string

L Kadletz

http://www.w3.org/2001/XMLSchema#string

R Schmid

http://www.w3.org/2001/XMLSchema#string

S Schneider

http://www.w3.org/2001/XMLSchema#string

U Kotowski

http://www.w3.org/2001/XMLSchema#string

P2860

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.

Clonogenic assay of cells in vitro.

Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines.

P304

797-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ODI.12552

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregor Heiduschka

Markus Brunner

Rudolf Seemann

P577

2016-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27476950

http://www.w3.org/2001/XMLSchema#string